Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Anupam Rasayan IPO is 42. Their analysis recommends Avoid, However active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 42 | Avoid, However active risk seekers can try |
[Dilip Davda] Based on the companyââ‚-â„¢s financial data, the issue appears aggressively priced. However, considering the rising fancy for life care and speciality chemicals segment linked with future performance trends, the company is expected to do well post listing going forward. Based on these aspects, investors looking for a long term bet may consider investing in this IPO. Read detail review...
Anupam Rasayan IPO Reviews, analysis and views by popular members. Read Anupam Rasayan India Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: